Myeloablative Allogeneic Bone Marrow Transplant Using T Cell Depleted Allografts Followed by Post-Transplant GM-CSF in High Risk Myelodysplastic Syndromes

Allogeneic blood and marrow transplantation (alloBMT) remains the only curative treatment for patients with myelodysplastic syndromes (MDS), but its application has been limited by the older age range of patients with this disease. T cell depletion decreases transplant-related toxicity related to gr...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Warlick, Erica D., O'Donnell, Paul V., Borowitz, Michael, Grupka, Nichon, Decloe, Lauren, Garrett-Mayer, Elizabeth, Borrello, Ivan, Brodsky, Robert, Fuchs, Ephraim, Huff, Carol Ann, Luznik, Leo, Matsui, William, Ambinder, Richard, Jones, Richard J., Smith, B. Douglas
Format: Artigo
Idioma:Inglês
Publicat: 2008
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC2719785/
https://ncbi.nlm.nih.gov/pubmed/18261793
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.leukres.2007.12.017
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars